KELIX Bio is a biopharmaceutical company that specializes in the development and distribution of high-complexity generic medicines, targeting underserved populations in emerging markets, particularly in Egypt and North Africa. The company focuses on differentiated therapeutic areas, including oncology, and aims to enhance the availability and affordability of essential pharmaceuticals in these regions. By leveraging innovation and cost leadership, KELIX Bio seeks to address the challenges faced by healthcare systems in providing access to critical medications, ultimately improving health outcomes for patients in its markets.
DiabTec is a unit of Julphar that manufactures recombinant human Insulin API services.
Pharmaceutical Institute
Acquisition in 2022
Pharmaceutical Institute is a manufacturer and distributor of pharmaceutical products located in Ain El Aouda, Morocco. The company specializes in producing medications that address a range of health issues, including fungal infections, inflammation, digestive disorders, urogenital conditions, central nervous system ailments, and antihistamines. Additionally, Pharmaceutical Institute provides contract manufacturing services for various pharmaceutical brands worldwide. With a robust distribution network and manufacturing capabilities, the company aims to enhance the availability of affordable and life-saving medications across Africa, aligning with broader initiatives to improve healthcare access in the region.
Chemi
Acquisition in 2021
Chemi is an Italian pharmaceutical company.
Celon Laboratories
Acquisition in 2020
Celon Laboratories Pvt. Ltd., established in 2001 and headquartered in Hyderabad, India, is a specialty generics company focused on research, development, manufacturing, and marketing of pharmaceutical products. Its portfolio includes branded and generic formulations in the niche therapy areas of oncology and critical care, serving markets in Asia, Africa, Latin America, and Eastern Europe. The company's product range comprises various dosage forms such as tablets, capsules, ampoules, vials, pre-filled syringes, and emulsion injections. Additionally, Celon offers contract research manufacturing services, including formulation development, lyophilization cycle development, quality control testing, stability studies, and regulatory support. As of 2020, Celon operates as a subsidiary of ZNZ Pharma 2 Ltd.
ADWIA Pharmaceuticals
Acquisition in 2020
ADWIA Pharmaceuticals is an Egyptian company that specializes in the development, manufacturing, and marketing of health products for both human and veterinary use. The company offers a range of generic drugs and focuses on animal health products tailored for various species in production markets. Additionally, ADWIA Pharmaceuticals is involved in the production formulation and delivery of human pharmaceutical and pesticide products, catering to a wide array of health needs across different sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.